Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Matthew W. Nelson, PharmD, BCPP
JCP
Letter to the Editor
Reply to "Galantamine and QTc Prolongation"
January 15, 2007
Matthew W. Nelson
,
Robert W. Buchanan
JCP
Letter to the Editor
Galantamine-Induced QTc Prolongation
January 16, 2006
Matthew W. Nelson
,
Robert W. Buchanan
JCP
Letter to the Editor
Adjuvant Therapeutic Effects of Galantamine on Apathy in a Schizophrenia Patient
December 15, 2004
David S. Arnold
,
Richard B. Rosse
,
Dwight Dickinson
, et al
